BIOMAT Database Logo BIOMAT Database Logo

Calcium acetate versus calcium carbonate and erythropoietin dosages in haemodialysis patients. 1995

M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Hospital Pharmacy Midden-Brabant, Tilburg, The Netherlands.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D008297 Male Males
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002119 Calcium Carbonate Carbonic acid calcium salt (CaCO3). An odorless, tasteless powder or crystal that occurs in nature. It is used therapeutically as a phosphate buffer in hemodialysis patients and as a calcium supplement. Aragonite,Calcite,Chalk,Limestone,Marble,Milk of Calcium,Vaterite,Calcium Milk,Carbonate, Calcium
D004333 Drug Administration Routes The various ways of administering a drug or other chemical to a site in a patient or animal from where the chemical is absorbed into the blood and delivered to the target tissue. Administration Routes, Drug,Administration Route, Drug,Drug Administration Route,Route, Drug Administration,Routes, Drug Administration
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup

Related Publications

M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium acetate versus calcium carbonate as phosphorus binders in patients on chronic haemodialysis: a controlled study.
January 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium acetate versus calcium carbonate as phosphate binders in hemodialysis patients.
January 1992, Nephron,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Comparison of calcium acetate with calcium carbonate as phosphate binder in patients on maintenance haemodialysis.
January 2007, Journal of Ayub Medical College, Abbottabad : JAMC,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium acetate versus calcium carbonate as phosphate binders.
January 1993, Nephron,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients.
November 2000, Sao Paulo medical journal = Revista paulista de medicina,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium acetate versus calcium carbonate as oral phosphate binder in pediatric and adolescent hemodialysis patients.
October 1996, Pediatric nephrology (Berlin, Germany),
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium acetate versus calcium carbonate for the control of serum phosphorus in hemodialysis patients.
January 1994, American journal of nephrology,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients.
January 2014, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia,
M J Janssen, and A van der Kuy, and P M ter Wee, and W P van Boven
Calcium ketoglutarate versus calcium acetate for treatment of hyperphosphataemia in patients on maintenance haemodialysis: a cross-over study.
June 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!